Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-resistant tuberculosis clinical trials: proposed core research definitions in adults.
Furin J, Alirol E, Allen E, Fielding K, Merle C, Abubakar I, Andersen J, Davies G, Dheda K, Diacon A, Dooley KE, Dravnice G, Eisenach K, Everitt D, Ferstenberg D, Goolam-Mahomed A, Grobusch MP, Gupta R, Harausz E, Harrington M, Horsburgh CR, Lienhardt C, McNeeley D, Mitnick CD, Nachman S, Nahid P, Nunn AJ, Phillips P, Rodriguez C, Shah S, Wells C, Thomas-Nyang'wa B, du Cros P. Furin J, et al. Among authors: wells c. Int J Tuberc Lung Dis. 2016 Mar;20(3):290-4. doi: 10.5588/ijtld.15.0490. Int J Tuberc Lung Dis. 2016. PMID: 27046707 Free PMC article.
Delamanid in the treatment of multidrug-resistant tuberculosis.
Gupta R, Wells CD, Hittel N, Hafkin J, Geiter LJ. Gupta R, et al. Among authors: wells cd. Int J Tuberc Lung Dis. 2016 Dec 1;20(12):33-37. doi: 10.5588/ijtld.16.0125. Int J Tuberc Lung Dis. 2016. PMID: 28240570 Review.
Pan-tuberculosis regimens: re-framing the argument.
Gupta R, Wells CD. Gupta R, et al. Lancet Respir Med. 2018 Jul;6(7):e28. doi: 10.1016/S2213-2600(18)30189-9. Lancet Respir Med. 2018. PMID: 29976444 No abstract available.
Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
Gammino VM, Taylor AB, Rich ML, Bayona J, Becerra MC, Bonilla C, Gelmanova I, Hollo V, Jaramillo E, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riektsina V, Tupasi TE, Wells CD, Zignol M, Cegielski PJ. Gammino VM, et al. Among authors: wells cd. Int J Tuberc Lung Dis. 2011 Oct;15(10):1315-22. doi: 10.5588/ijtld.10.0221. Int J Tuberc Lung Dis. 2011. PMID: 22283887
Multidrug-resistant tuberculosis management in resource-limited settings.
Nathanson E, Lambregts-van Weezenbeek C, Rich ML, Gupta R, Bayona J, Blöndal K, Caminero JA, Cegielski JP, Danilovits M, Espinal MA, Hollo V, Jaramillo E, Leimane V, Mitnick CD, Mukherjee JS, Nunn P, Pasechnikov A, Tupasi T, Wells C, Raviglione MC. Nathanson E, et al. Among authors: wells c. Emerg Infect Dis. 2006 Sep;12(9):1389-97. doi: 10.3201/eid1209.051618. Emerg Infect Dis. 2006. PMID: 17073088 Free PMC article.
Delamanid for Extensively Drug-Resistant Tuberculosis.
Gupta R, Geiter LJ, Wells CD, Gao M, Cirule A, Xiao H. Gupta R, et al. N Engl J Med. 2015 Jul 16;373(3):291-2. doi: 10.1056/NEJMc1415332. N Engl J Med. 2015. PMID: 26176402 Free article. Clinical Trial. No abstract available.
2,035 results